(R)-2-Amino-2-(3,5-difluorophenyl)ethanol hydrochloride is primarily used in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a chiral center and difluorophenyl group, makes it valuable for developing enantiomerically pure compounds, particularly in the creation of drugs targeting central nervous system disorders.

This compound is often employed in the production of selective serotonin reuptake inhibitors (SSRIs) and other psychotropic medications, where its specific stereochemistry enhances the drug's efficacy and reduces side effects. Additionally, it is utilized in research and development for designing novel therapeutic agents, particularly those requiring fluorinated aromatic systems for improved metabolic stability and bioavailability. Its role in medicinal chemistry underscores its importance in advancing treatments for complex neurological and psychiatric conditions.